Pierandrea Muglia
Patrimonio netto: 352 195 $ in data 30/06/2026
Patrimonio netto: 352 195 $ in data 30/06/2026
Pierandrea Muglia was the founder of GRIN Therapeutics, Inc., founded in 2021, and served as President from 2021 to 2022.
The current jobs include Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2025.
Former jobs include Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SANIONA AB 0,19% | 31/12/2024 | 259.999 ( 0,19% ) | 352 195 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANA AB | Direttore Tecnico/Scientifico/R&S | 10/03/2025 |
| Società | Posizione | Fine |
|---|---|---|
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Fondatore | 01/09/2022 |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/10/2019 |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Vendite & Marketing | - |
| NTG NORDIC TRANSPORT GROUP A/S | Direttore/Membro del Consiglio | 28/05/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Health Technology |
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale